Literature DB >> 11139115

Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.

D A Olin1, F Urdaneta, E B Lobato.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11139115     DOI: 10.1053/jcan.2000.18531

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


× No keyword cloud information.
  2 in total

1.  Why is the platelet count low: should I be concerned about heparin-induced thrombocytopenia?

Authors:  Christopher Lancaster; Joseph D Tobias
Journal:  J Pediatr Pharmacol Ther       Date:  2012-01

Review 2.  Danaparoid: a review of its use in thromboembolic and coagulation disorders.

Authors:  Tim Ibbotson; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.